These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9498271)

  • 1. The DNA damaging drug cyproterone acetate causes gene mutations and induces glutathione-S-transferase P in the liver of female Big Blue transgenic F344 rats.
    Krebs O; Schäfer B; Wolff T; Oesterle D; Deml E; Sund M; Favor J
    Carcinogenesis; 1998 Feb; 19(2):241-5. PubMed ID: 9498271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part II. Multiple dose treatment.
    Topinka J; Oesterle D; Reimann R; Wolff T
    Mutat Res; 2004 Jun; 550(1-2):101-8. PubMed ID: 15135644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No-effect level in the mutagenic activity of the drug cyproterone acetate in rat liver. Part I. Single dose treatment.
    Topinka J; Oesterle D; Reimann R; Wolff T
    Mutat Res; 2004 Jun; 550(1-2):89-99. PubMed ID: 15135643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes.
    Werner S; Kunz S; Beckurts T; Heidecke CD; Wolff T; Schwarz LR
    Mutat Res; 1997 Dec; 395(2-3):179-87. PubMed ID: 9465929
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose dependent induction of DNA adducts, gene mutations, and cell proliferation by the antiandrogenic drug cyproterone acetate in rat liver.
    Wolff T; Topinka J; Deml E; Oesterle D; Schwarz LR
    Adv Exp Med Biol; 2001; 500():687-96. PubMed ID: 11765015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyproterone acetate generates DNA adducts in rat liver and in primary rat hepatocyte cultures.
    Topinka J; Andrae U; Schwarz LR; Wolff T
    Carcinogenesis; 1993 Mar; 14(3):423-7. PubMed ID: 8453718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA-damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver.
    Topinka J; Binkova B; Zhu HK; Andrae U; Neumann I; Schwarz LR; Werner S; Wolff T
    Carcinogenesis; 1995 Jul; 16(7):1483-7. PubMed ID: 7542174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accumulation and persistence of DNA adducts of the synthetic steroid cyproterone acetate in rat liver.
    Werner S; Topinka J; Wolff T; Schwarz LR
    Carcinogenesis; 1995 Oct; 16(10):2369-72. PubMed ID: 7586137
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-dependent formation of preneoplastic foci and DNA adducts in rat liver with 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeA alpha C) and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
    Hasegawa R; Takahashi S; Shirai T; Iwasaki S; Kim DJ; Ochiai M; Nagao M; Sugimura T; Ito N
    Carcinogenesis; 1992 Aug; 13(8):1427-31. PubMed ID: 1499093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyproterone acetate: a genotoxic carcinogen?
    Kasper P
    Pharmacol Toxicol; 2001 May; 88(5):223-31. PubMed ID: 11393581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyproterone acetate is an integral part of hepatic DNA adducts induced by this steroidal drug.
    Topinka J; Binkova B; Schwarz LR; Wolff T
    Carcinogenesis; 1996 Jan; 17(1):167-9. PubMed ID: 8565129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation.
    Werner S; Kunz S; Wolff T; Schwarz LR
    Cancer Res; 1996 Oct; 56(19):4391-7. PubMed ID: 8813132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro mutagenicity studies on cyproterone acetate using female rat hepatocytes for metabolic activation and as indicator cells.
    Kasper P; Tegethoff K; Mueller L
    Carcinogenesis; 1995 Oct; 16(10):2309-14. PubMed ID: 7586127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA adduct formation and T lymphocyte mutation induction in F344 rats implanted with tumorigenic doses of 1,6-dinitropyrene.
    Beland FA
    Res Rep Health Eff Inst; 1995 Oct; (72):1-27; discussion 29-39. PubMed ID: 11381742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sex-specific dose-response analysis of genotoxicity in cyproterone acetate-treated F344 rats.
    Ding W; Bishop ME; Pearce MG; Davis KJ; White GA; Lyn-Cook LE; Manjanatha MG
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Nov; 774():1-7. PubMed ID: 25440904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NTP technical report on the toxicity and metabolism studies of chloral hydrate (CAS No. 302-17-0). Administered by gavage to F344/N rats and B6C3F1 mice.
    Beland FA
    Toxic Rep Ser; 1999 Aug; (59):1-66, A1-E7. PubMed ID: 11803702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initiation of enzyme-altered foci by the synthetic steroid cyproterone acetate in rat liver foci bioassay.
    Deml E; Schwarz LR; Oesterle D
    Carcinogenesis; 1993 Jun; 14(6):1229-31. PubMed ID: 8099540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time-related induction of DNA repair synthesis in rat hepatocytes following in vivo treatment with cyproterone acetate.
    Kasper P; Mueller L
    Carcinogenesis; 1996 Oct; 17(10):2271-4. PubMed ID: 8895500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long term phenobarbital administration does not promote the multiplication of hepatocytes replicating after single cyproterone acetate administration.
    Pichard V; Ferry N
    Life Sci; 2005 May; 76(26):3057-68. PubMed ID: 15850598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyproterone acetate: is it hepato- or genotoxic?
    Rabe T; Feldmann K; Heinemann L; Runnebaum B
    Drug Saf; 1996 Jan; 14(1):25-38. PubMed ID: 8713486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.